SEC Form 4 · accession 0001209191-15-071214
Ignyta, Inc. · RXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Igor Bilinsky
Officer — GM, Immuno-Oncology/SVP Sp Ops
Period of report
Sep 17, 2015
Accepted (ET)
Sep 17, 2015 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557421
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $16.75 | Sep 17, 2015 | A | 200,000 | A | — | Sep 16, 2025 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The option is exercisable as it vests. 25% of the total number of shares subject to the option vest on September 17, 2016, and 1/48th of the total number of shares subject to the option vest monthly thereafter.